Curex Tirzepatide Review: Prices, Care and Refund Conflicts

Curex advertises compounded tirzepatide injections and oral dissolving tablets, with medication, clinical review and shipping presented together. Its pages do not provide one consistent price-and-policy picture. Compare the chosen preparation and renewal terms before treating a starting price or refund headline as your agreement.^3,4

Starting prices are not a complete renewal quote

The home-linked GLP-1 page advertises a first month from $149 for each tirzepatide format. Its $49 first-month headline applies to semaglutide, not the named tirzepatide cards. The page also uses a general “from $199/mo” message.³

A separate product page lists both tirzepatide formats from $199, but the individual cards do not specify the billing period or quantity beside that price. Neither display establishes your dose-specific continuing bill. Request the preparation, supplied quantity, payment frequency and future price together.⁴

Both pages promote no membership fee and free shipping. The separate product page promises online consultation, medication and follow-up support; its FAQ excludes recommended laboratory work and additional medicines from the plan. A package can include clinical review without covering every future test or treatment.⁴

The formulation and pharmacy matter

The reviewed offer is for compounded products rather than Zepbound or Mounjaro. A pharmacy-made preparation is not an FDA-approved finished medicine. Our guide to compounded tirzepatide’s legal status explains the distinction. Tablets should not be assumed to have the evidence, absorption or outcomes of branded injections.⁴

Curex markets third-party testing and state-licensed pharmacy fulfillment. These are company claims, not independent verification of a particular pharmacy, batch or laboratory certificate. Its statement about FDA/DEA-certified laboratories does not establish FDA approval of the compounded product. Obtain the dispensing pharmacy and preparation details for your prescription.⁴

FDA issued a warning letter to Curex dated September 9, 2025 concerning false or misleading compounded-drug marketing. The letter remains relevant to evaluating equivalence claims; it does not establish the outcome of an individual order or whether every current statement has been resolved.⁸

Clinical access and state restrictions

The legal documents distinguish Curex Inc.’s platform from Curex Medical Services P.A., Curex Medical of California P.C. and Curex Medical of New Jersey P.C. Clinical decisions rest with providers, and the pharmacy network is described without assigning a particular dispenser to every patient.⁵

Telehealth may involve video or asynchronous communication. The consent warns that response times vary and that in-person care can be needed. Messaging access is not an emergency service or a tested response-time guarantee.^5,7

Coverage claims conflict. The home-linked page says all fifty states, with California limited to tablets; the separate product FAQ excludes seven states. The linked legal state list differs again, including some states named in those exclusions. Confirm availability for your actual location and formulation before paying.^3,4,6

Discuss your own suitability and safety concerns with a clinician, including Zepbound side effects, gallbladder risk, and the thyroid warning. Those branded-drug resources do not validate Curex’s specific preparation.

Refund advertising and the contract do not align

The GLP-1 page promises a full refund if medication is not prescribed and advertises a conditional 365-day weight-loss guarantee. The linked Terms instead make completed consultations nonrefundable up to $100, regardless of whether medication is dispensed or shipped. Obtain written clarification; neither headline alone establishes a guaranteed net refund.^3,5

The Terms renew subscriptions automatically unless canceled by phone or email. Monthly cancellation or pause must precede fulfillment, which includes compounding or preparation—not just shipment. One-time purchases are distinguished from subscriptions. Unused prepaid months and partly used periods are generally nonrefundable; courtesy exceptions are discretionary.⁵

These financial questions deserve the same attention as the medication price. Ask when preparation begins, how to stop the next order and what fee remains if a clinician declines treatment. A promise that you can cancel does not undo an order already being prepared.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Comparing the full arrangement

Compare Cielo and DoctorAdam on their own preparation, billing and care disclosures. The provider comparison is another starting point. Curex’s appeal is a published combination of medication and clinical support; its material limitations are inconsistent public terms, uncertain individual supply pricing and the need to distinguish compounded preparations from branded trial evidence.